ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation

Wang, Shou-Jia; Ye, Wen; Li, Wan-Yi; Tian, Wen; Zhang, Meng; Sun, Yang; Feng, Ying-Da; Liu, Chen-Xu; Liu, Shao-Yuan; Cao, Wei; Meng, Jing-Ru*; Li, Xiao-Qiang*哈尔滨医科大学; 西北农林科技大学; 中国人民解放军第四军医大学
Journal of Ethnopharmacology2023-3-1DOI: 10.1016/j.jep.2022.116053
6被引28阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Liver fibrosis is a potentially harmful chronic liver disease caused by various etiologies. There is currently no specific drug for liver fibrosis. Xiaochaihu Tang (XCHT) is a traditional formula combined of seven herbs, which was first recorded in the Treatise on Febrile Diseases in Han Dynasty of ancient China. It is widely used in clinic to hepatic protection, analgesic, antipyretic and anti-inflammatory treatment. And it has been recommended for treating chronic hepatitis and chronic cholecystitis in the latest guidelines for the diagnosis and treatment of liver fibrosis with integrated traditional and western medicine. However, the underlying regulatory mechanisms remain elusive.Aim of the study: This study aims to explore the therapeutic effects of XCHT on liver fibrosis and its underlying molecular mechanisms from the perspective of network pharmacology and experimental research.Materials and methods: Carbon tetrachloride (CCl4) induced and bile duct ligation (BDL) induced liver fibrosis models in mice were established to evaluate the anti-fibrosis effects of XCHT in vivo. Potential anti-fibrosis targets of XCHT were screened via network establishment. The underlying mechanisms were uncovered through GO and pathway enrichment analysis. Then, the core targets were identified from protein-protein interaction network by means of the Cytohubba plug-in of Cytoscape. Furthermore, two effective monomer components of XCHT were recognized by molecular docking. Moreover, the predicted components and pathways were verified by in vitro experiments.Results: When treated with XCHT, liver fibrosis was alleviated in both mice models, showing as the improvement of liver function, the protection of hepatocytes, the inhibition of HSC activation and the reduction of hepatic collagen accumulation. 540 monomer components, 300 therapeutic targets, 109 signaling pathways, 246 GO biological processes, 77 GO cellular components, 107 GO molecular functions items and core targets were identified by network analysis. Then, 6-gingerol and baicalein were identified as the core components of anti-fibrosis effects of XCHT via leptin or Nrf2 signaling pathway. Furthermore, the experiment in vitro also validated the results.Conclusions: Our study suggests XCHT could alleviate liver fibrosis through multi-targets and multi-pathways; 6-gingerol and baicalein are its core components which may play an important role via leptin or Nrf2 signaling pathway.

学科与关键词

关键词
Liver fibrosisXiaochaihu TangNetwork pharmacologyActive componentsLeptin signaling pathwayNrf2 signaling pathway
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-03-01
卷期
第 303 卷
页码
116053
DOI
10.1016/j.jep.2022.116053
语言
ENGLISH
成果收录
SCIE
资助标注
Shaanxi Administration of Traditional Chinese Medicine [2022-SLRH-YQ-004, 2021-04-ZZ-001, 2021-QYPT-003, 2021-ZZ-JC006]; Multidisciplinary research capacity improvement project of TCM based on the research field of state key laboratory, National Administration of Traditional Chinese Medicine; National Natural Science Foundation of China [82004059, 81970245, 82270357]; Science and Technology Project of Shaanxi Province in China [2022YWZX-PG-01, 2019SF-035, 2019 PT-23]

作者

  • W

    Wang, Shou-Jia (第一作者)

    fourth mil med univ

  • Y

    Ye, Wen

    fourth mil med univ

查看全部 12 位作者收起作者
  • L

    Li, Wan-Yi

    harbin med univ

  • T

    Tian, Wen

    fourth mil med univ

  • Z

    Zhang, Meng

    fourth mil med univ

  • S

    Sun, Yang

    fourth mil med univ

  • F

    Feng, Ying-Da

    fourth mil med univ

  • L

    Liu, Chen-Xu

    fourth mil med univ

  • L

    Liu, Shao-Yuan

    fourth mil med univ

  • C

    Cao, Wei

    fourth mil med univ · northwest a&f univ

  • M

    Meng, Jing-Ru (通讯)

    fourth mil med univ

  • L

    Li, Xiao-Qiang (通讯)

    fourth mil med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417